Wednesday, May 23, 2012

8:00 a.m.


8:25 a.m. Overview of CPRIT Dean Sherry, Ph.D.
8:30 a.m. Animal Models of Cancer: Motivation for In Vivo Studies Robert Bachoo, M.D., Ph.D.
9:05 a.m. Progress in Quantitative Evaluation of Hyperpolarized Carbon Tracers In Vivo Jim Bankson, Ph.D.
9:40 a.m.

Advances in RF Coil Design for High Field Imaging in Patients

Steve Wright, Ph.D.
10:15 a.m. Break
10:40 a.m. Reprogramming Metabolism in Cancer Ralph DeBerardinis, M.D., Ph.D.
11:15 a.m. Cancer Metabolism and Clinical Translation Elizabeth Maher, M.D., Ph.D.
11:50 a.m. Discussion
12:00 Noon Lunch
1:00 p.m. Intermediary Metabolism by 13C NMR Shawn Burgess, Ph.D.
1:40 p.m. Metabolism in the Fatty and Fasted Human Liver    Jeff Browning, M.D.
2:10 p.m. Hyperpolarized 13C Matthew Merritt, Ph.D.
2:50 p.m. Discussion and Break
3:15 p.m. Physiology of Substrate Oxidation in the Heart Chalermchai Khemtong, Ph.D.
3:45 p.m.

11C for Analysis of Metabolism In Vivo

Robert Mach, Ph.D.
4:30 p.m. Discussion and Reception
Thursday, May 24, 2012
8:00 a.m.


8:30 a.m. Overview of Clinical Translational Imaging Neil Rofsky, M.D.
9:15 a.m. PET Probes on the Horizon Charles Manning, Ph.D.
10:00 a.m. Break
10:15 a.m. Integrated PET/MR Ciprian Catana, M.D., Ph.D.
11:00 a.m. Imaging the Heart with Hyperpolarized 13C Charles Cunningham, Ph.D.
12:00 Noon Lunch

1:00 p.m.

Bench to Bedside with PET: 11C-hydroxyephedrine Imaging of the Heart John Canty, Jr., M.D.
1:45 p.m. Bench to Bedside with 13C: Imaging Prostate Cancer John Kurhanewicz, Ph.D.
2:30 p.m. Break
3:00 p.m. Opportunities and Realities in Translational Imaging Peter Choyke, M.D.
3:45 p.m. Translational Imaging in Drug Development Paul Matthews, M.D.
4:30 p.m. Discussion and Adjournment